Aster DM Health. Cash flow Statement
Figures in Cr
Consolidated Cash Flow Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
No of Months
12
12
12
12
12
12
Profit Before Tax
5,542.00
330.00
535.00
636.00
205.00
330.00
Adjustment
-4,862.00
1,570.00
1,269.00
1,136.00
1,179.00
1,136.00
Changes In working Capital
-140.00
-1,671.00
87.00
-401.00
195.00
-177.00
Cash Flow after changes in Working Capital
539.00
229.00
1,892.00
1,371.00
1,580.00
1,288.00
Cash Flow from Operating Activities
425.00
157.00
1,833.00
1,314.00
1,569.00
1,223.00
Cash Flow from Investing Activities
6,015.00
-878.00
-950.00
-563.00
-333.00
-658.00
Cash Flow from Financing Activities
-6,357.00
1,052.00
-817.00
-686.00
-1,116.00
-674.00
Net Cash Inflow / Outflow
82.00
332.00
65.00
64.00
119.00
-109.00
Opening Cash & Cash Equivalents
82.00
365.00
299.00
234.00
114.00
224.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
164.00
697.00
365.00
299.00
234.00
114.00
Figures in INR Cr
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Aster DM Health.
Figures in Cr
consolidated Cash Flow Results
Change(INR)
Change(%)
Profit Before Tax
5542.26
790.63
4,752.00
600.99%
Adjustment
-4862.24
537.11
-5,399.00
-1005.26%
Changes In working Capital
-140.46
-214.97
74.00
34.66%
Cash Flow after changes in Working Capital
539.56
1112.77
-573.00
-51.51%
Cash Flow from Operating Activities
425.05
985.78
-560.00
-56.88%
Cash Flow from Investing Activities
6015.12
-1324.67
7,339.00
554.08%
Cash Flow from Financing Activities
-6357.81
544.31
-6,901.00
-1268.05%
Net Cash Inflow / Outflow
82.36
205.42
-123.00
-59.91%
Opening Cash & Cash Equivalents
82.23
241.74
-159.00
-65.98%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
164.59
447.16
-283.00
-63.19%
Cash Flow - Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is 169.34% vs -91.40% in Mar 2024
Mar'25
Mar'24
Change(%)
Cash Flow from Operating Activities
425.05
157.81
169.34%






